A convolutional-recurrent neural network approach to resting-state EEG classification in Parkinson's disease

Drug-resistant juvenile myoclonic epilepsy: A literature review

The ILAE's Task Force on Nosology and Definitions revised in 2022 its definition of juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy disorder, but this definition may well change again in the future. Although good drug response could almost be a diagnostic criterion for JME, drug resistance (DR) is observed in up to a third of patients. It is important to distinguish this from pseudoresistance, which is often linked to psychosocial problems or psychiatric comorbidities. After summarizing these aspects and the various definitions applied to JME, the present review lists the risk factors for DR-JME that have been identified in numerous studies and meta-analyses. The factors most often cited are absence seizures, young age at onset, and catamenial seizures. By contrast, photosensitivity seems to favor good treatment response, at least in female patients. Current hypotheses on DR mechanisms in JME are based on studies of either simple (e.g., cortical excitability) or more complex (e.g., anatomical and functional connectivity) neurophysiological markers, bearing in mind that JME is regarded as a neural network disease. This research has revealed correlations between the intensity of some markers and DR, and above all shed light on the role of these markers in associated neurocognitive and neuropsychiatric disorders in both patients and their siblings. Studies of neurotransmission have mainly pointed to impaired GABAergic inhibition. Genetic studies have generally been inconclusive. Increasing restrictions have been placed on the use of valproate, the standard antiseizure medication for this syndrome, owing to its teratogenic and developmental risks. Levetiracetam and lamotrigine are prescribed as alternatives, as is vagal nerve stimulation, and there are several other promising antiseizure drugs and neuromodulation methods. The development of better alternative treatments is continuing to take place alongside advances in our knowledge of JME, as we still have much to learn and understand.

Parkinson's disease diagnosis using deep learning: A bibliometric analysis and literature review

Parkinson's Disease (PD) is a progressive neurodegenerative illness triggered by decreased dopamine secretion. Deep Learning (DL) has gained substantial attention in PD diagnosis research, with an increase in the number of published papers in this discipline. PD detection using DL has presented more promising outcomes as compared with common machine learning approaches. This article aims to conduct a bibliometric analysis and a literature review focusing on the prominent developments taking place in this area. To achieve the target of the study, we retrieved and analyzed the available research papers in the Scopus database. Following that, we conducted a bibliometric analysis to inspect the structure of keywords, authors, and countries in the surveyed studies by providing visual representations of the bibliometric data using VOSviewer software. The study also provides an in-depth review of the literature focusing on different indicators of PD, deployed approaches, and performance metrics. The outcomes indicate the firm development of PD diagnosis using DL approaches over time and a large diversity of studies worldwide. Additionally, the literature review presented a research gap in DL approaches related to incremental learning, particularly in relation to big data analysis.

Identifying EEG Biomarkers of Depression with Novel Explainable Deep Learning Architectures

Deep learning methods are increasingly being applied to raw electroencephalogram (EEG) data. However, if these models are to be used in clinical or research contexts, methods to explain them must be developed, and if these models are to be used in research contexts, methods for combining explanations across large numbers of models must be developed to counteract the inherent randomness of existing training approaches. Model visualization-based explainability methods for EEG involve structuring a model architecture such that its extracted features can be characterized and have the potential to offer highly useful insights into the patterns that they uncover. Nevertheless, model visualization-based explainability methods have been underexplored within the context of multichannel EEG, and methods to combine their explanations across folds have not yet been developed. In this study, we present two novel convolutional neural network-based architectures and apply them for automated major depressive disorder diagnosis. Our models obtain slightly lower classification performance than a baseline architecture. However, across 50 training folds, they find that individuals with MDD exhibit higher β power, potentially higher δ power, and higher brain-wide correlation that is most strongly represented within the right hemisphere. This study provides multiple key insights into MDD and represents a significant step forward for the domain of explainable deep learning applied to raw EEG. We hope that it will inspire future efforts that will eventually enable the development of explainable EEG deep learning models that can contribute both to clinical care and novel medical research discoveries.

An interpretable model based on graph learning for diagnosis of Parkinson's disease with voice-related EEG

Parkinson's disease (PD) exhibits significant clinical heterogeneity, presenting challenges in the identification of reliable electroencephalogram (EEG) biomarkers. Machine learning techniques have been integrated with resting-state EEG for PD diagnosis, but their practicality is constrained by the interpretable features and the stochastic nature of resting-state EEG. The present study proposes a novel and interpretable deep learning model, graph signal processing-graph convolutional networks (GSP-GCNs), using event-related EEG data obtained from a specific task involving vocal pitch regulation for PD diagnosis. By incorporating both local and global information from single-hop and multi-hop networks, our proposed GSP-GCNs models achieved an averaged classification accuracy of 90.2%, exhibiting a significant improvement of 9.5% over other deep learning models. Moreover, the interpretability analysis revealed discriminative distributions of large-scale EEG networks and topographic map of microstate MS5 learned by our models, primarily located in the left ventral premotor cortex, superior temporal gyrus, and Broca's area that are implicated in PD-related speech disorders, reflecting our GSP-GCN models' ability to provide interpretable insights identifying distinctive EEG biomarkers from large-scale networks. These findings demonstrate the potential of interpretable deep learning models coupled with voice-related EEG signals for distinguishing PD patients from healthy controls with accuracy and elucidating the underlying neurobiological mechanisms.

The applied principles of EEG analysis methods in neuroscience and clinical neurology

Electroencephalography (EEG) is a non-invasive measurement method for brain activity. Due to its safety, high resolution, and hypersensitivity to dynamic changes in brain neural signals, EEG has aroused much interest in scientific research and medical fields. This article reviews the types of EEG signals, multiple EEG signal analysis methods, and the application of relevant methods in the neuroscience field and for diagnosing neurological diseases. First, three types of EEG signals, including time-invariant EEG, accurate event-related EEG, and random event-related EEG, are introduced. Second, five main directions for the methods of EEG analysis, including power spectrum analysis, time-frequency analysis, connectivity analysis, source localization methods, and machine learning methods, are described in the main section, along with different sub-methods and effect evaluations for solving the same problem. Finally, the application scenarios of different EEG analysis methods are emphasized, and the advantages and disadvantages of similar methods are distinguished. This article is expected to assist researchers in selecting suitable EEG analysis methods based on their research objectives, provide references for subsequent research, and summarize current issues and prospects for the future.

Differentiating Between Alzheimer's Disease and Frontotemporal Dementia Based on the Resting-State Multilayer EEG Network

Frontotemporal dementia (FTD) is frequently misdiagnosed as Alzheimer's disease (AD) due to similar clinical symptoms. In this study, we constructed frequency-based multilayer resting-state electroencephalogram (EEG) networks and extracted representative network features to improve the differentiation between AD and FTD. When compared with healthy controls (HC), AD showed primarily stronger delta-alpha cross-couplings and weaker theta-sigma cross-couplings. Notably, when comparing the AD and FTD groups, we found that the AD exhibited stronger delta-alpha and delta-beta connectivity than the FTD. Thereafter, by extracting the representative network features and then applying these features in the classification between AD and FTD, an accuracy of 81.1% was achieved. Finally, a multivariable linear regressive model was built, based on the differential topologies, and then adopted to predict the scores of the Mini-Mental State Examination (MMSE) scale. Accordingly, the predicted and actual measured scores were indeed significantly correlated with each other ( r = 0.274, p = 0.036). These findings consistently suggest that frequency-based multilayer resting-state networks can be utilized for classifying AD and FTD and have potential applications for clinical diagnosis.

EEG-Based Parkinson's Disease Recognition via Attention-Based Sparse Graph Convolutional Neural Network

Parkinson's disease (PD) is a complicated neurological ailment that affects both the physical and mental wellness of elderly individuals which makes it problematic to diagnose in its initial stages. Electroencephalogram (EEG) promises to be an efficient and cost-effective method for promptly detecting cognitive impairment in PD. Nevertheless, prevailing diagnostic practices utilizing EEG features have failed to examine the functional connectivity among EEG channels and the response of associated brain areas causing an unsatisfactory level of precision. Here, we construct an attention-based sparse graph convolutional neural network (ASGCNN) for diagnosing PD. Our ASGCNN model uses a graph structure to represent channel relationships, the attention mechanism for selecting channels, and the L1 norm to capture channel sparsity. We conduct extensive experiments on the publicly available PD auditory oddball dataset, which consists of 24 PD patients (under ON/OFF drug status) and 24 matched controls, to validate the effectiveness of our method. Our results show that the proposed method provides better results compared to the publicly available baselines. The achieved scores for Recall, Precision, F1-score, Accuracy and Kappa measures are 90.36%, 88.43%, 88.41%, 87.67%, and 75.24%, respectively. Our study reveals that the frontal and temporal lobes show significant differences between PD patients and healthy individuals. In addition, EEG features extracted by ASGCNN demonstrate significant asymmetry in the frontal lobe among PD patients. These findings can offer a basis for the establishment of a clinical system for intelligent diagnosis of PD by using auditory cognitive impairment features.

A review of emergent intelligent systems for the detection of Parkinson's disease

Parkinson's disease (PD) is a neurodegenerative disorder affecting people worldwide. The PD symptoms are divided into motor and non-motor symptoms. Detection of PD is very crucial and essential. Such challenges can be overcome by applying artificial intelligence to diagnose PD. Many studies have also proposed the implementation of computer-aided diagnosis for the detection of PD. This systematic review comprehensively analyzed all appropriate algorithms for detecting and assessing PD based on the literature from 2012 to 2023 which are conducted as per PRISMA model. This review focused on motor symptoms, namely handwriting dynamics, voice impairments and gait, multimodal features, and brain observation using single photon emission computed tomography, magnetic resonance and electroencephalogram signals. The significant challenges are critically analyzed, and appropriate recommendations are provided. The critical discussion of this review article can be helpful in today's PD community in such a way that it allows clinicians to provide proper treatment and timely medication.

Electroencephalogram-Driven Machine-Learning Scenario for Assessing Impulse Control Disorder Comorbidity in Parkinson's Disease Using a Low-Cost, Custom LEGO-Like Headset

Patients with Parkinson's disease (PD) may develop cognitive symptoms of impulse control disorders (ICDs) when chronically treated with dopamine agonist (DA) therapy for motor deficits. Motor and cognitive comorbidities critically increase the disability and mortality of the affected patients. This study proposes an electroencephalogram (EEG)-driven machine-learning scenario to automatically assess ICD comorbidity in PD. We employed a classic Go/NoGo task to appraise the capacity of cognitive and motoric inhibition with a low-cost, custom LEGO-like headset to record task-relevant EEG activity. Further, we optimized a support vector machine (SVM) and support vector regression (SVR) pipeline to learn discriminative EEG spectral signatures for the detection of ICD comorbidity and the estimation of ICD severity, respectively. With a dataset of 21 subjects with typical PD, 9 subjects with PD and ICD comorbidity (ICD), and 25 healthy controls (HC), the study results showed that the SVM pipeline differentiated subjects with ICD from subjects with PD with an accuracy of 66.3% and returned an around-chance accuracy of 53.3% for the classification of PD versus HC subjects without the comorbidity concern. Furthermore, the SVR pipeline yielded significantly higher severity scores for the ICD group than for the PD group and resembled the ICD vs. PD distinction according to the clinical questionnaire scores, which was barely replicated by random guessing. Without a commercial, high-precision EEG product, our demonstration may facilitate deploying a wearable computer-aided diagnosis system to assess the risk of DA-triggered cognitive comorbidity in patients with PD in their daily environment.

EEG-based classification of individuals with neuropsychiatric disorders using deep neural networks: A systematic review of current status and future directions

The use of deep neural networks for electroencephalogram (EEG) classification has rapidly progressed and gained popularity in recent years, but automatic feature extraction from EEG signals remains a challenging task. The classification of neuropsychiatric disorders demands the extraction of neuro-markers for use in automated EEG classification. Numerous advanced deep learning algorithms can be used for this purpose. In this article, we present a comprehensive review of the main factors and parameters that affect the performance of deep neural networks in classifying different neuropsychiatric disorders using EEG signals. We also analyze the EEG features used for improving classification performance. Our analysis includes 82 scientific journal papers that applied deep neural networks for subject-wise classification based on EEG signals. We extracted information on the EEG dataset and types of disorders, deep neural network structures, performance, and hyperparameters. The results show that most studies have focused on clinical classification, achieving an average accuracy of 91.83 ± 7.34, with convolutional neural networks (CNNs) being the most frequently used network architecture and resting-state EEG signals being the most commonly used data type. Additionally, the review reveals that depression (N = 18), Alzheimer's (N = 11), and schizophrenia (N = 11) were studied more frequently than other types of neuropsychiatric disorders. Our review provides insight into the performance of deep neural networks in EEG classification and highlights the importance of EEG feature extraction in improving classification accuracy. By identifying the main factors and parameters that affect deep neural network performance in EEG classification, our review can guide future research in this area. We hope that our findings will encourage further exploration of deep learning methods for EEG classification and contribute to the development of more accurate and effective methods for diagnosing and monitoring neuropsychiatric disorders using EEG signals.

Automatic detection of Parkinson's disease from power spectral density of electroencephalography (EEG) signals using deep learning model

Parkinson's disease (PD) is characterized by slowed movements, speech disorders, an inability to control muscle movements, and tremors in the hands and feet. In the early stages of PD, the changes in these motor signs are very vague, so an objective and accurate diagnosis is difficult. The disease is complex, progressive, and very common. There are more than 10 million people worldwide suffering from PD. In this study, an EEG-based deep learning model was proposed for the automatic detection of PD to support experts. The EEG dataset comprises signals recorded by the University of Iowa from 14 PD patients and 14 healthy controls. First of all, the power spectral density values (PSDs) ​​of the frequencies between 1 and 49 Hz of the EEG signals were calculated separately using periodogram, welch, and multitaper spectral analysis methods. 49 feature vectors were extracted for each of the three different experiments. Then, the performances of support vector machine, random forest, k-nearest neighbor, and bidirectional long-short-term memory (BiLSTM) algorithms were compared using the PSDs feature vectors. After the comparison, the model integrating welch spectral analysis and the BiLSTM algorithm showed the highest performance as a result of the experiments. The deep learning model achieved satisfactory performance with 0.965 specificity, 0.994 sensitivity, 0.964 precision, 0.978 f1-score, 0.958 Matthews correlation coefficient, and 97.92% accuracy. The study is a promising attempt to detect PD from EEG signals and it also provides evidence that deep learning algorithms are more effective than machine learning algorithms for EEG signal analysis.

Evaluating methods of oversampling and averaging resting-state electroencephalography data in classifying Parkinson's disease. ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY. ANNUAL INTERNATIONAL CONFERENCE 2023;2023:1-5. [PMID: 38082678 DOI: 10.1109/embc40787.2023.10340819] [Citation(s) in RCA: 0] [Impact Index Per Article: 0]

Collecting resting-state electroencephalography (RSEEG) data is time-consuming and data sets are therefore often small. Because many machine learning (ML) algorithms work better with ample data, researchers looking to use RSEEG and ML to develop diagnostic models have used oversampling methods that may seem to contradict averaging methods used in conventional electroencephalography (EEG) research to improve the signal-to-noise ratio. Using eyes open (EO) and eyes closed (EC) recordings from 3 different research groups, we investigated the effect of different averaging and oversampling methods on classification metrics when classifying people with Parkinson's disease (PD) and controls. Both EC and EO recordings were used due to differences found between these methods. Our results indicated that grouping 58 electrodes into regions-of-interest (ROI) based on anatomical location is preferable to using single electrodes. Furthermore, although recording EO data led to slightly better classification, the number of data points for each participant was reduced and recordings for three participants entirely lost during pre-processing due to a higher level of artefacts than in the EC data.Clinical relevance- RSEEG is a potential biomarker for the diagnosis and prognostication of PD, but for RSEEG to have clinical relevance, it is necessary to establish which averaging and oversampling of data most reliably segregates the classes for people with PD and controls. We found that using of ROIs and EC data performed the best, as EO data was often contaminated with artefacts.

Multi-scale convolutional recurrent neural network for psychiatric disorder identification in resting-state EEG

Background

Accurate classification based on affordable objective neuroimaging biomarkers are important steps toward designing individualized treatment.

Methods

In this work, we investigated a deep learning classification model, multi-scale convolutional recurrent neural network (MCRNN), to explore psychiatric disorder-related biomarkers by leveraging the spatiotemporal information of resting-state EEG (rsEEG) using a multiple psychiatric disorder database containing 327 individuals diagnosed with schizophrenia, bipolar, major depressive disorders, and healthy controls. All subjects were mapped to a shared low-dimensional subspace for intuitively interpreting the inter-relationship and separation of psychiatric disorders.

Results

Psychiatric disorders were identified using rsEEG with high accuracy ranged from 78.6 to 91.3% in patient vs. controls two-class classification, and 68.2% in four-class classification. The control-to-schizophrenia trajectory interpretated by the model was consistent with the disease severity in clinical observation.

Conclusion

The MsRNN demonstrated a capability in extracting discriminative rsEEG biomarkers for psychiatric disorder classification, indicating its potential to facilitate our understanding of psychiatric disorders and monitoring interventions.

Distinguishing Parkinson's Disease with GLCM Features from the Hankelization of EEG Signals

This study proposes a novel method that uses electroencephalography (EEG) signals to classify Parkinson's Disease (PD) and demographically matched healthy control groups. The method utilizes the reduced beta activity and amplitude decrease in EEG signals that are associated with PD. The study involved 61 PD patients and 61 demographically matched controls groups, and EEG signals were recorded in various conditions (eyes closed, eyes open, eyes both open and closed, on-drug, off-drug) from three publicly available EEG data sources (New Mexico, Iowa, and Turku). The preprocessed EEG signals were classified using features obtained from gray-level co-occurrence matrix (GLCM) features through the Hankelization of EEG signals. The performance of classifiers with these novel features was evaluated using extensive cross-validations (CV) and leave-one-out cross-validation (LOOCV) schemes. This method under 10 × 10 fold CV, the method was able to differentiate PD groups from healthy control groups using a support vector machine (SVM) with an accuracy of 92.4 ± 0.01, 85.7 ± 0.02, and 77.1 ± 0.06 for New Mexico, Iowa, and Turku datasets, respectively. After a head-to-head comparison with state-of-the-art methods, this study showed an increase in the classification of PD and controls.

Are the EEG microstates correlated with motor and non-motor parameters in patients with Parkinson's disease?

OBJECTIVES

This study compared electroencephalography microstates (EEG-MS) of patients with Parkinson's disease (PD) to healthy controls and correlated EEG-MS with motor and non-motor aspects of PD.

METHODS

This cross-sectional exploratory study was conducted with patients with PD (n = 10) and healthy controls (n = 10) matched by sex and age. We recorded EEG-MS using 32 channels during eyes-closed and eyes-open conditions and analyzed the four classic EEG-MS maps (A, B, C, D). Clinical information (e.g., disease duration, medications, levodopa equivalent daily dose), motor (Movement Disorder Society - Unified Parkinson Disease Rating Scale II and III, Timed Up and Go simple and dual-task, and Mini-Balance Evaluation Systems Test) and non-motor aspects (Mini-Mental State Exam [MMSE], verbal fluency, Hospital Anxiety and Depression Scale, and Parkinson's Disease Questionnaire-39 [PDQ-39]) were assessed in the PD group. Mann-Whitney U test was used to compare groups, and Spearman's correlation coefficient to analyze the correlations between coverage of EEG-MS and clinical aspects of PD.

RESULTS

The PD group showed a shorter duration of EEG-MS C in the eyes-closed condition than the control group. We observed correlations (rho = 0.64 to 0.82) between EEG-MS B, C, and D and non-motor aspects of PD (MMSE, verbal fluency, PDQ-39, and levodopa equivalent daily dose).

CONCLUSION

Alterations in EEG-MS and correlations between topographies and cognitive aspects, quality of life, and medication dose indicate that EEG could be used as a PD biomarker. Future studies should investigate these associations using a longitudinal design.

Detection of Parkinson's disease from EEG signals using discrete wavelet transform, different entropy measures, and machine learning techniques

Early detection of Parkinson's disease (PD) is very important in clinical diagnosis for preventing disease development. In this study, we present efficient discrete wavelet transform (DWT)-based methods for detecting PD from health control (HC) in two cases, namely, off-and on-medication. First, the EEG signals are preprocessed to remove major artifacts before being decomposed into several EEG sub-bands (approximate and details) using DWT. The features are then extracted from the wavelet packet-derived reconstructed signals using different entropy measures, namely, log energy entropy, Shannon entropy, threshold entropy, sure entropy, and norm entropy. Several machine learning techniques are investigated to classify the resulting PD/HC features. The effects of DWT coefficients and brain regions on classification accuracy are being investigated as well. Two public datasets are used to verify the proposed methods: the SanDiego dataset (31 subjects, 93 min) and the UNM dataset (54 subjects, 54 min). The results are promising and show that four entropy measures: log energy entropy, threshold entropy, sure entropy, and modified-Shannon entropy (TShEn) lead to high classification accuracy, indicating they are good biomarkers for PD detection. With the SanDiego dataset, the classification results of off-medication PD versus HC are 99.89, 99.87, and 99.91 for accuracy, sensitivity, and specificity, respectively, using the combination of DWT + TShEn and KNN classifier. Using the same combination, the results of on-medication PD versus HC are 94.21, 93.33, and 95%. With the UNM dataset, the obtained classification accuracy is around 99.5% in both cases of off-and on-medication PD using DWT + TShEn + SVM and DWT + ThEn + KNN, respectively. The results also demonstrate the importance of all DWT coefficients and that selecting a suitable small number of EEG channels from several brain regions could improve the classification accuracy.

Parkinson's disease is characterized by sub-second resting-state spatio-oscillatory patterns: A contribution from deep convolutional neural network

Deep convolutional neural network (DCNN) provides a multivariate framework to detect relevant spatio-oscillatory patterns in the data beyond common mass-univariate statistics. Yet, its practical application is limited due to the low interpretability of the results beyond accuracy. We opted to use DCNN with a minimalistic architecture design and large penalized terms to yield a generalizable and clinically relevant network model. Our network was trained based on the scalp topology of the electroencephalography (EEG) from an open access dataset, constituting our primary sample of healthy controls (n = 25) and Parkinson's disease (PD) patients (n = 25), with and without medication. Next, we validated the model on another independent, yet comparable open access EEG dataset (healthy controls (n = 20) and PD patients (n = 20)), which was unseen to the network. We applied Gradient-weighted Class Activation Mapping (Grad-CAM) interpretability technique to create a localization map exhibiting the key network predictors, based on the gradients of the classification score flowing into the last convolutional layer. Accordingly, our results indicated that a sub-second of intrinsic oscillatory power pattern in the beta band over the occipitoparietal, gamma band over the left motor cortex as well as theta band over the frontoparietal cluster, had the largest impact on the network score for dissociating the PD patients from age- and gender-matched healthy controls, across the two datasets. We further found that the off-medication motor symptoms were related to the occipitoparietal off-medication beta power whereas the disease duration was associated with the off-medication beta power of the motor cortex. The on-medication theta power of the frontoparietal was related to the improvement of the motor symptoms. In conclusion, our method enabled us to characterize PD patho-electrophysiology according to the multivariate topographic analysis approach, where both spatial and frequency aspects of the oscillations were simultaneously considered. Moreover, our approach was free from common reference problem of the EEG data analyses.

Parkinson’s disease detection based on multi-pattern analysis and multi-scale convolutional neural networks

Parkinson’s disease (PD) is a complex neurodegenerative disease. At present, the early diagnosis of PD is still extremely challenging, and there is still a lack of consensus on the brain characterization of PD, and a more efficient and robust PD detection method is urgently needed. In order to further explore the features of PD based on brain activity and achieve effective detection of PD patients (including OFF and ON medications), in this study, a multi-pattern analysis based on brain activation and brain functional connectivity was performed on the brain functional activity of PD patients, and a novel PD detection model based on multi-scale convolutional neural network (MCNN) was proposed. Based on the analysis of power spectral density (PSD) and phase-locked value (PLV) features of multiple frequency bands of two independent resting-state electroencephalography (EEG) datasets, we found that there were significant differences in PSD and PLV between HCs and PD patients (including OFF and ON medications), especially in the β and γ bands, which were very effective for PD detection. Moreover, the combined use of brain activation represented by PSD and functional connectivity patterns represented by PLV can effectively improve the performance of PD detection. Furthermore, our proposed MCNN model shows great potential for automatic PD detection, with cross-validation accuracy, sensitivity, specificity, and area under the receiver operating characteristic curve all above 99%. Our study may help to further understand the characteristics of PD and provide new ideas for future PD diagnosis based on spontaneous EEG activity.

Transcranial Current Stimulation as a Tool of Neuromodulation of Cognitive Functions in Parkinson’s Disease

Decrease in cognitive function is one of the most common causes of poor life quality and early disability in patients with Parkinson’s disease (PD). Existing methods of treatment are aimed at both correction of motor and non-motor symptoms. Methods of adjuvant therapy (or complementary therapy) for maintaining cognitive functions in patients with PD are of interest. A promising subject of research in this regard is the method of transcranial electric current stimulation (tES). Here we reviewed the current understanding of the pathogenesis of cognitive impairment in PD and of the effects of transcranial direct current stimulation and transcranial alternating current stimulation on the cognitive function of patients with PD-MCI (Parkinson’s Disease–Mild Cognitive Impairment).

Survey of Machine Learning Techniques in the Analysis of EEG Signals for Parkinson’s Disease: A Systematic Review

Background: Parkinson’s disease (PD) affects 7–10 million people worldwide. Its diagnosis is clinical and can be supported by image-based tests, which are expensive and not always accessible. Electroencephalograms (EEG) are non-invasive, widely accessible, low-cost tests. However, the signals obtained are difficult to analyze visually, so advanced techniques, such as Machine Learning (ML), need to be used. In this article, we review those studies that consider ML techniques to study the EEG of patients with PD. Methods: The review process was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, which are used to provide quality standards for the objective evaluation of various studies. All publications before February 2022 were included, and their main characteristics and results were evaluated and documented through three key points associated with the development of ML techniques: dataset quality, data preprocessing, and model evaluation. Results: 59 studies were included. The predominating models were Support Vector Machine (SVM) and Artificial Neural Networks (ANNs). In total, 31 articles diagnosed PD with a mean accuracy of 97.35 ± 3.46%. There was no standard cleaning protocol for EEG and a great heterogeneity in EEG characteristics was shown, although spectral features predominated by 88.37%. Conclusions: Neither the cleaning protocol nor the number of EEG channels influenced the classification results. A baseline value was provided for the PD diagnostic problem, although recent studies focus on the identification of cognitive impairment.

CNN Architectures and Feature Extraction Methods for EEG Imaginary Speech Recognition

Speech is a complex mechanism allowing us to communicate our needs, desires and thoughts. In some cases of neural dysfunctions, this ability is highly affected, which makes everyday life activities that require communication a challenge. This paper studies different parameters of an intelligent imaginary speech recognition system to obtain the best performance according to the developed method that can be applied to a low-cost system with limited resources. In developing the system, we used signals from the Kara One database containing recordings acquired for seven phonemes and four words. We used in the feature extraction stage a method based on covariance in the frequency domain that performed better compared to the other time-domain methods. Further, we observed the system performance when using different window lengths for the input signal (0.25 s, 0.5 s and 1 s) to highlight the importance of the short-term analysis of the signals for imaginary speech. The final goal being the development of a low-cost system, we studied several architectures of convolutional neural networks (CNN) and showed that a more complex architecture does not necessarily lead to better results. Our study was conducted on eight different subjects, and it is meant to be a subject’s shared system. The best performance reported in this paper is up to 37% accuracy for all 11 different phonemes and words when using cross-covariance computed over the signal spectrum of a 0.25 s window and a CNN containing two convolutional layers with 64 and 128 filters connected to a dense layer with 64 neurons. The final system qualifies as a low-cost system using limited resources for decision-making and having a running time of 1.8 ms tested on an AMD Ryzen 7 4800HS CPU.

Layer recurrent neural network-based diagnosis of Parkinson’s disease using voice features

Parkinson’s disease (PD), a slow-progressing neurological disease, affects a large percentage of the world’s elderly population, and this population is expected to grow over the next decade. As a result, early detection is crucial for community health and the future of the globe in order to take proper safeguards and have a less arduous treatment procedure. Recent research has begun to focus on the motor system deficits caused by PD. Because practically most of the PD patients suffer from voice abnormalities, researchers working on automated diagnostic systems investigate vocal impairments. In this paper, we undertake extensive experiments with features extracted from voice signals. We propose a layer Recurrent Neural Network (RNN) based diagnosis for PD. To prove the efficiency of the model, different network models are compared. To the best of our knowledge, several neural network topologies, namely RNN, Cascade Forward Neural Networks (CFNN), and Feed Forward Neural Networks (FFNN), are used and compared for voice-based PD detection for the first time. In addition, the impacts of data normalization and feature selection (FS) are thoroughly examined. The findings reveal that normalization increases classifier performance and Laplacian-based FS outperforms. The proposed RNN model with 300 voice features achieves 99.74% accuracy.

Parkinson’s Disease Detection from Resting-State EEG Signals Using Common Spatial Pattern, Entropy, and Machine Learning Techniques

Parkinson’s disease (PD) is a very common brain abnormality that affects people all over the world. Early detection of such abnormality is critical in clinical diagnosis in order to prevent disease progression. Electroencephalography (EEG) is one of the most important PD diagnostic tools since this disease is linked to the brain. In this study, novel efficient common spatial pattern-based approaches for detecting Parkinson’s disease in two cases, off–medication and on–medication, are proposed. First, the EEG signals are preprocessed to remove major artifacts before spatial filtering using a common spatial pattern. Several features are extracted from spatially filtered signals using different metrics, namely, variance, band power, energy, and several types of entropy. Machine learning techniques, namely, random forest, linear/quadratic discriminant analysis, support vector machine, and k-nearest neighbor, are investigated to classify the extracted features. The impacts of frequency bands, segment length, and reduction number on the results are also investigated in this work. The proposed methods are tested using two EEG datasets: the SanDiego dataset (31 participants, 93 min) and the UNM dataset (54 participants, 54 min). The results show that the proposed methods, particularly the combination of common spatial patterns and log energy entropy, provide competitive results when compared to methods in the literature. The achieved results in terms of classification accuracy, sensitivity, and specificity in the case of off-medication PD detection are around 99%. In the case of on-medication PD, the results range from 95% to 98%. The results also reveal that features extracted from the alpha and beta bands have the highest classification accuracy.

Deep Transfer Learning for Parkinson’s Disease Monitoring by Image-Based Representation of Resting-State EEG Using Directional Connectivity

Parkinson’s disease (PD) is characterized by abnormal brain oscillations that can change rapidly. Tracking neural alternations with high temporal resolution electrophysiological monitoring methods such as EEG can lead to valuable information about alterations observed in PD. Concomitantly, there have been advances in the high-accuracy performance of deep neural networks (DNNs) using few-patient data. In this study, we propose a method to transform resting-state EEG data into a deep latent space to classify PD subjects from healthy cases. We first used a general orthogonalized directed coherence (gOPDC) method to compute directional connectivity (DC) between all pairwise EEG channels in four frequency bands (Theta, Alpha, Beta, and Gamma) and then converted the DC maps into 2D images. We then used the VGG-16 architecture (trained on the ImageNet dataset) as our pre-trained model, enlisted weights of convolutional layers as initial weights, and fine-tuned all layer weights with our data. After training, the classification achieved 99.62% accuracy, 100% precision, 99.17% recall, 0.9958 F1 score, and 0.9958 AUC averaged for 10 random repetitions of training/evaluating on the proposed deep transfer learning (DTL) network. Using the latent features learned by the network and employing LASSO regression, we found that latent features (as opposed to the raw DC values) were significantly correlated with five clinical indices routinely measured: left and right finger tapping, left and right tremor, and body bradykinesia. Our results demonstrate the power of transfer learning and latent space derivation for the development of oscillatory biomarkers in PD.

Application of Deep Learning Models for Automated Identification of Parkinson's Disease: A Review (2011-2021)

Parkinson’s disease (PD) is the second most common neurodegenerative disorder affecting over 6 million people globally. Although there are symptomatic treatments that can increase the survivability of the disease, there are no curative treatments. The prevalence of PD and disability-adjusted life years continue to increase steadily, leading to a growing burden on patients, their families, society and the economy. Dopaminergic medications can significantly slow down the progression of PD when applied during the early stages. However, these treatments often become less effective with the disease progression. Early diagnosis of PD is crucial for immediate interventions so that the patients can remain self-sufficient for the longest period of time possible. Unfortunately, diagnoses are often late, due to factors such as a global shortage of neurologists skilled in early PD diagnosis. Computer-aided diagnostic (CAD) tools, based on artificial intelligence methods, that can perform automated diagnosis of PD, are gaining attention from healthcare services. In this review, we have identified 63 studies published between January 2011 and July 2021, that proposed deep learning models for an automated diagnosis of PD, using various types of modalities like brain analysis (SPECT, PET, MRI and EEG), and motion symptoms (gait, handwriting, speech and EMG). From these studies, we identify the best performing deep learning model reported for each modality and highlight the current limitations that are hindering the adoption of such CAD tools in healthcare. Finally, we propose new directions to further the studies on deep learning in the automated detection of PD, in the hopes of improving the utility, applicability and impact of such tools to improve early detection of PD globally.